Nautilus Raises Fourth Round

Nautilus Biotech, a Paris, France-based biotech company focused on therapeutic proteins, has raised Euro 8.4 million in fourth-round funding. Participants included Creabilis Biotech, Ed. de Rothschild Investment Partners, Auriga Partners, Matignon Technologies, Pre-IPO Invest, FCJE, 123 Ventures and Genopole 1er Jour. www.nautilusbiotech.com